| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AUPH | Aurinia Pharmaceuticals Inc. | Huizinga Robert Bindert | EVP of Research | Mar 02, 2022 | Sale | $12.01 | 4,849 | 58,236 | 69,379 | Mar 04, 2022, 04:10 PM | |
| AUPH | Aurinia Pharmaceuticals Inc. | Huizinga Robert Bindert | EVP of Research | Oct 25, 2021 | Sale | $18.54 | 225,000 | 4,171,500 | 195,728 | Oct 26, 2021, 04:33 PM | |
| AUPH | Aurinia Pharmaceuticals Inc. | Huizinga Robert Bindert | EVP of Research | Sep 21, 2021 | Sale | $14.37 | 59,636 | 857,248 | 133,228 | Sep 22, 2021, 04:53 PM | |
| AUPH | Aurinia Pharmaceuticals Inc. | Huizinga Robert Bindert | EVP of Research | Sep 10, 2021 | Sale | $19.80 | 10,000 | 197,950 | 133,592 | Sep 14, 2021, 05:12 PM | |
| AUPH | Aurinia Pharmaceuticals Inc. | Huizinga Robert Bindert | EVP of Research | Sep 14, 2021 | Sale | $21.75 | 22,500 | 489,375 | 106,092 | Sep 14, 2021, 05:12 PM | |
| AUPH | Aurinia Pharmaceuticals Inc. | Huizinga Robert Bindert | EVP of Research | Sep 07, 2021 | Sale | $18.30 | 5,000 | 91,500 | 138,592 | Sep 08, 2021, 04:03 PM |
Menu